As of Jun 22, 2026, the Pro Dex stock's PE ratio is 17.41. This results from the current EPS of $3.7 and stock price of $64.4. The P/E ratio has an increase of 39% from the past four quarters average of 12.6.
The PE ratio of Pro Dex has averaged 15.07 over the last ten years. The current PE ratio of 17.41 is 16% above the historical average. Over the past ten years, PDEX's PE ratio was at its highest in the Jun 2024 quarter at 32.2, when the stock price was $19.64 and the EPS was $0.61. The lowest value was in the Mar 2017 quarter, when it reached 4.07 with a price of $4.6 and an EPS of $1.13.
Maximum annual increase: 258.61% in 2018
Maximum annual decrease: -82.45% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 15.99 | -50.34% | $43.64 | $2.73 |
| 2024 | 32.2 | 233.68% | $19.64 | $0.61 |
| 2023 | 9.65 | -23.78% | $19.1 | $1.98 |
| 2022 | 12.66 | -32.48% | $15.95 | $1.26 |
| 2021 | 18.75 | 64.19% | $30.56 | $1.63 |
| 2020 | 11.42 | -12.89% | $17.82 | $1.56 |
| 2019 | 13.11 | -25.09% | $12.98 | $0.99 |
| 2018 | 17.5 | 258.61% | $6.65 | $0.38 |
| 2017 | 4.88 | -82.45% | $6.15 | $1.26 |
| 2016 | 27.8 | N/A | $5.56 | $0.2 |
| 2015 | N/A | N/A | $2.34 | -$0.09 |
| 2014 | N/A | N/A | $2.1 | -$0.14 |
| 2013 | N/A | N/A | $1.9 | -$0.54 |
| 2012 | N/A | N/A | $2.03 | -$0.27 |
| 2011 | 2.57 | N/A | $2.08 | $0.81 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 13.28 | 19.75% | $49.12 | $3.7 |
| Dec 2025 | 11.09 | 12.36% | $38.48 | $3.47 |
| Sep 2025 | 9.87 | -38.27% | $33.85 | $3.43 |
| Jun 2025 | 15.99 | -8.1% | $43.64 | $2.73 |
| Mar 2025 | 17.4 | -24.08% | $49.58 | $2.85 |
| Dec 2024 | 22.92 | 19% | $46.75 | $2.04 |
| Sep 2024 | 19.26 | -40.19% | $29.85 | $1.55 |
| Jun 2024 | 32.2 | 6.13% | $19.64 | $0.61 |
| Mar 2024 | 30.34 | 47.21% | $17.6 | $0.58 |
| Dec 2023 | 20.61 | 94.25% | $17.52 | $0.85 |
| Sep 2023 | 10.61 | 9.95% | $15.7 | $1.48 |
| Jun 2023 | 9.65 | 26.47% | $19.1 | $1.98 |
| Mar 2023 | 7.63 | -12.7% | $16.41 | $2.15 |
| Dec 2022 | 8.74 | -35.88% | $15.9 | $1.82 |
| Sep 2022 | 13.63 | 7.66% | $17.72 | $1.3 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
PDEX's current P/E ratio is above the 5 and 10-year historical averages, but it is below the 3-year average.
Pro Dex's P/E of 17.41 is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 24.1, Pro Dex's P/E is 28% lower.
Compared to its peer stocks TMO and DHR, PDEX's PE ratio stands lower. Pro Dex is presently trading at a lower PE ratio (17.41) than its peer group average of 30.09.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PDEX Pro Dex Inc | 17.26 | $203.89M |
| MDT Medtronic plc | 21.42 | $102.83B |
| TMO Thermo Fisher Scientific Inc | 25.64 | $173.57B |
| ALGN Align Technology Inc | 28.84 | $12.33B |
| DHR Danaher Corp | 34.29 | $125.95B |
| TDG TransDigm Group INC | 40.3 | $72.27B |
| RVP Retractable Technologies Inc | N/A | $20.25M |
| XRAY DENTSPLY SIRONA Inc | N/A | $2.03B |
The price to earnings ratio for PDEX stock as of Jun 22, 2026, stands at 17.41.
The 3-year average PE ratio for PDEX stock is 17.77.
The 5-year average PE ratio for PDEX stock is 16.18.
In the last ten years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 32.2.
PDEX's price to earnings ratio is currently 16% above its 10-year historical average.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Jun 22, 2026), Pro Dex's stock price is $64.4. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $3.7. Therefore, Pro Dex's P/E ratio for today is 17.41. PE RATIO(17.41) = STOCK PRICE($64.4) / TTM EPS($3.7)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.